| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.3 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |